Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$63.64 - $125.14 $3,691 - $7,258
-58 Closed
0 $0
Q1 2024

Apr 29, 2024

BUY
$85.37 - $115.44 $4,951 - $6,695
58 New
58 $6,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $21.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Silicon Valley Capital Partners Portfolio

Follow Silicon Valley Capital Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silicon Valley Capital Partners, based on Form 13F filings with the SEC.

News

Stay updated on Silicon Valley Capital Partners with notifications on news.